A 32-Year-Old Man Presented with Nephrotic Syndrome Due to Systemic Lupus Erythematosus Developed Lupus Cerebritis, Pancytopenia and Renal Failure: The Need for New Biologicals
Main Article Content
Abstract
Case Summary
A 32-year-old man presented with nephrotic syndrome due to membranous nephropathy, secondary to systemic lupus erythematosus (SLE). During intensive immunosuppressive therapy with corticosteroid and cyclophosphamide, the patient developed confusion, fits (lupus cerebritis), pancytopenia and rapidly rising serum creatinine (end stage renal failure). Plasmapheresis and rituximab therapy did not make improvement. Later, the patient had gastro-intestinal bleeding, ARDS secondary to bacterial pneumonia, fits and succumbed. Multiple cerebral hemorrhages, consolidation and bilateral small kidneys were found in autopsy.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Aftab, A., Saleem, N., Abbas, S. F., Ullah, Z., & Haneef, M. (2022). Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab. Case Reports in Gastrointestinal Medicine, 2022, 3443141. https://doi.org/10.1155/2022/3443141
II. Alduraibi, F. K., & Tsokos, G. C. (2024). Lupus Nephritis Biomarkers: A Critical Review. International Journal of Molecular Sciences, 25(2). https://doi.org/10.3390/ijms25020805
III. Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020). Lupus nephritis. Nature Reviews. Disease Primers, 6(1), 7. https://doi.org/10.1038/s41572-019-0141-9
IV. Bashal, F. (2013). Hematological disorders in patients with systemic lupus erythematosus. The Open Rheumatology Journal, 7, 87–95. https://doi.org/10.2174/1874312901307010087
V. Burt, R. K., Traynor, A., Statkute, L., Barr, W. G., Rosa, R., Schroeder, J., Verda, L., Krosnjar, N., Quigley, K., Yaung, K., Villa, B., Marcello, Takahashi, M., Jovanovic, B., & Oyama, Y. (2006). Nonmyeloablative Hematopoietic Stem Cell Transplantation for Systemic Lupus Erythematosus. JAMA, 295(5), 527–535.
https://doi.org/10.1001/jama.295.5.527
VI. Chalayer, E., Ffrench, M., & Cathébras, P. (2014). Bone marrow fibrosis as a feature of systemic lupus erythematosus: A case report and literature review. SpringerPlus, 3, 349. https://doi.org/10.1186/2193-1801-3-349
VII. El Miedany, Y., Elhadidi, K., Mahmoud, G. A., Abu-Zaid, M. H., Mahmoud, A. A., El Gaafary, M., Kamel, N., Fathi, N. A., Nasser, A. A., Hassan, W., Eissa, M., Sarhan, E., Aboalfadl, E., Mansour, A. E., Mortada, M., Fouad, N. A., Elaraby, I., Elnemr, R., Medhat, B. M., … Mokbel, A. (2023). Egyptian recommendations for the management of systemic lupus erythematosus: A consensus, evidence-based, clinical practice guidelines for treat-to-target management. Egyptian Rheumatology and Rehabilitation, 50(1), 23.
https://doi.org/10.1186/s43166-023-00187-9
VIII. Fanouriakis, A., Kostopoulou, M., Andersen, J., Aringer, M., Arnaud, L., Bae, S.-C., Boletis, J., Bruce, I. N., Cervera, R., Doria, A., Dörner, T., Furie, R. A., Gladman, D. D., Houssiau, F. A., Inês, L. S., Jayne, D., Kouloumas, M., Kovács, L., Mok, C. C., … Boumpas, D. T. (2024). EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases, 83(1), 15.
https://doi.org/10.1136/ard-2023-224762
IX. Fekih-Romdhane, F., Ghrissi, F., Hallit, S., & Cheour, M. (2023). New-onset acute psychosis as a manifestation of lupus cerebritis following concomitant COVID-19 infection and vaccination: A rare case report. BMC Psychiatry, 23(1), 419. https://doi.org/10.1186/s12888-023-04924-4
X. Gansner, J. M., & Berliner, N. (2018). The rheumatology/hematology interface: CAPS and MAS diagnosis and management. Hematology, 2018(1), 313–317.
https://doi.org/10.1182/asheducation-2018.1.313
XI. Lee, J., Dhillon, N., & Pope, J. (2013). All-cause hospitalizations in systemic lupus erythematosus from a large Canadian referral centre. Rheumatology, 52(5), 905–909.
https://doi.org/10.1093/rheumatology/kes391
XII. Magro-Checa, C., Zirkzee, E. J., Huizinga, T. W., & Steup-Beekman, G. M. (2016). Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives. Drugs, 76(4), 459–483.
https://doi.org/10.1007/s40265-015-0534-3
XIII. Schober, F. P., & Dooley, M. A. (2016). Management of Lupus Nephritis. Current Treatment Options in Rheumatology, 2(3), 225–238. https://doi.org/10.1007/s40674-016-0051-x
XIV. Schwartz, N., Stock, A. D., & Putterman, C. (2019). Neuropsychiatric lupus: New mechanistic insights and future treatment directions. Nature Reviews. Rheumatology, 15(3), 137–152.
https://doi.org/10.1038/s41584-018-0156-8
XV. Tanariyakul, M., Nebrajas, K., Saowapa, S., & Polpichai, N. (2024). Extensive Thrombosis in Catastrophic Antiphospholipid Syndrome in a Newly Diagnosed Systemic Lupus Erythematosus: A Case Report. Cureus, 16(5), e59542. https://doi.org/10.7759/cureus.59542
XVI. Vaishnav, B., Patil, S., Thakkar, N., & Sharma, P. (2023). Coexistence of Pancytopenia Due to Autoimmune Myelofibrosis and Seizures as Presenting Complaints in a Newly Diagnosed Case of Systemic Lupus Erythematosus – An Interesting Combination. Indian Journal of Rheumatology, 18(3). https://journals.lww.com/ijru/fulltext/2023/18030/coexistence_of_ pancytopenia_due_to_autoimmune.11.aspx
XVII. Yoshimi, R., Ueda, A., Ozato, K., & Ishigatsubo, Y. (2012). Clinical and pathological roles of Ro/SSA autoantibody system. Clinical & Developmental Immunology, 2012, 606195.